{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T09:21:05Z","timestamp":1794993665203,"version":"4.9.1"},"reference-count":51,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o de Amparo a Pesquisa do Estado do Rio de Janeiro and Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","award":["203.000\/2017"],"award-info":[{"award-number":["203.000\/2017"]}]},{"name":"Funda\u00e7\u00e3o de Amparo a Pesquisa do Estado do Rio de Janeiro and Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","award":["308488\/2019-9"],"award-info":[{"award-number":["308488\/2019-9"]}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["203.000\/2017"],"award-info":[{"award-number":["203.000\/2017"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["308488\/2019-9"],"award-info":[{"award-number":["308488\/2019-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Acromegaly is a chronic systemic disease caused in the vast majority of cases by growth hormone (GH)-secreting adenoma, with surgery being the first-line treatment. When a cure is not attained with surgery, first-generation somatostatin receptor ligands (fg-SRLs) are the most common medication prescribed. Predictors of response to fg-SRLs have been studied; however, they cannot fully predict the response to fg-SRL. MicroRNAs are small RNAs, the main role of which is messenger RNA (mRNA) post-transcriptional regulation. This study aimed to identify the microRNAs involved in resistance to treatment with fg-SRLs in acromegaly. Ten patients with acromegaly undergoing treatment with fg-SRLs were selected to undergo miRNA sequencing: five controlled and five uncontrolled with treatment. Bioinformatic analysis was performed to detect differentially expressed miRNAs. Then, the same 10 samples were used for validation by qPCR and an additional 22 samples were analyzed, totaling 32 samples. e We found 59 differentially expressed miRNAs in the first analysis. miR-181a-5p and miR-181b-5p were downregulated, and miR-383-5p was upregulated in the uncontrolled group. Receiver operating characteristic (ROC) curve analysis of miR-383-5p showed an NPV of 84.3% and a PPV of 84.5%. In summary, miR-181a-5p, miR-181b-5p, and miR-383-5p are biomarkers of response to fg-SRLs, and they can be used individually or included in prediction models as tools to guide clinical decisions.<\/jats:p>","DOI":"10.3390\/ijms24032875","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T02:57:24Z","timestamp":1675306644000},"page":"2875","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["miR-383-5p, miR-181a-5p, and miR-181b-5p as Predictors of Response to First-Generation Somatostatin Receptor Ligands in Acromegaly"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9514-0986","authenticated-orcid":false,"given":"Daniel G.","family":"Henriques","sequence":"first","affiliation":[{"name":"Endocrine Unit and Neuroendocrinology Research Center, Medical School and Hospital Universit\u00e1rio Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-617, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renan Lyra","family":"Miranda","sequence":"additional","affiliation":[{"name":"Neuropathology and Molecular Genetics Laboratory, Instituto Estadual do C\u00e9rebro Paulo Niemeyer, Rio de Janeiro 20231-092, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5838-0881","authenticated-orcid":false,"given":"R\u00f4mulo Sperduto","family":"Dezonne","sequence":"additional","affiliation":[{"name":"Neuropathology and Molecular Genetics Laboratory, Instituto Estadual do C\u00e9rebro Paulo Niemeyer, Rio de Janeiro 20231-092, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Eduardo","family":"Wildemberg","sequence":"additional","affiliation":[{"name":"Endocrine Unit and Neuroendocrinology Research Center, Medical School and Hospital Universit\u00e1rio Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-617, Brazil"},{"name":"Neuroendocrinology Division, Instituto Estadual do C\u00e9rebro Paulo Niemeyer, Rio de Janeiro 20231-092, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline Helen da Silva","family":"Camacho","sequence":"additional","affiliation":[{"name":"Neuropathology and Molecular Genetics Laboratory, Instituto Estadual do C\u00e9rebro Paulo Niemeyer, Rio de Janeiro 20231-092, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Chimelli","sequence":"additional","affiliation":[{"name":"Neuropathology and Molecular Genetics Laboratory, Instituto Estadual do C\u00e9rebro Paulo Niemeyer, Rio de Janeiro 20231-092, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1339-3192","authenticated-orcid":false,"given":"Leandro","family":"Kasuki","sequence":"additional","affiliation":[{"name":"Endocrine Unit and Neuroendocrinology Research Center, Medical School and Hospital Universit\u00e1rio Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-617, Brazil"},{"name":"Neuroendocrinology Division, Instituto Estadual do C\u00e9rebro Paulo Niemeyer, Rio de Janeiro 20231-092, Brazil"},{"name":"Endocrinology Division, Hospital Federal de Bonsucesso, Rio de Janeiro 21041-020, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa B.","family":"Lamback","sequence":"additional","affiliation":[{"name":"Endocrine Unit and Neuroendocrinology Research Center, Medical School and Hospital Universit\u00e1rio Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-617, Brazil"},{"name":"Neuropathology and Molecular Genetics Laboratory, Instituto Estadual do C\u00e9rebro Paulo Niemeyer, Rio de Janeiro 20231-092, Brazil"},{"name":"Neuroendocrinology Division, Instituto Estadual do C\u00e9rebro Paulo Niemeyer, Rio de Janeiro 20231-092, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8323-1477","authenticated-orcid":false,"given":"Alexandro","family":"Guterres","sequence":"additional","affiliation":[{"name":"Neuropathology and Molecular Genetics Laboratory, Instituto Estadual do C\u00e9rebro Paulo Niemeyer, Rio de Janeiro 20231-092, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica R.","family":"Gadelha","sequence":"additional","affiliation":[{"name":"Endocrine Unit and Neuroendocrinology Research Center, Medical School and Hospital Universit\u00e1rio Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-617, Brazil"},{"name":"Neuropathology and Molecular Genetics Laboratory, Instituto Estadual do C\u00e9rebro Paulo Niemeyer, Rio de Janeiro 20231-092, Brazil"},{"name":"Neuroendocrinology Division, Instituto Estadual do C\u00e9rebro Paulo Niemeyer, Rio de Janeiro 20231-092, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1210\/er.2018-00115","article-title":"Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update","volume":"40","author":"Gadelha","year":"2019","journal-title":"Endocr. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.20945\/2359-3997000000193","article-title":"Determinants of morbidities and mortality in acromegaly","volume":"63","author":"Kasuki","year":"2019","journal-title":"Arch. Endocrinol. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ecl.2020.05.007","article-title":"Acromegaly: Update on Management and Long-Term Morbidities","volume":"49","author":"Kasuki","year":"2020","journal-title":"Endocrinol Metab Clin North Am."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"924952","DOI":"10.3389\/fendo.2022.924952","article-title":"Acromegaly and Colorectal Neoplasm: An Update","volume":"13","author":"Kasuki","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11102-020-01091-7","article-title":"A Pituitary Society update to acromegaly management guidelines","volume":"24","author":"Fleseriu","year":"2021","journal-title":"Pituitary"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1210\/jc.2008-2421","article-title":"Guidelines for acromegaly management: An update","volume":"94","author":"Melmed","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12020-018-1590-8","article-title":"Predictors of surgical outcome and early criteria of remission in acromegaly","volume":"60","author":"Antunes","year":"2018","journal-title":"Endocrine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.yfrne.2013.07.005","article-title":"Somatostatin receptors: From signaling to clinical practice","volume":"34","author":"Theodoropoulou","year":"2013","journal-title":"Front. Neuroendocrinol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Gatto, F., Barbieri, F., Arvigo, M., Thellung, S., Amar\u00f9, J., Albertelli, M., Ferone, D., and Florio, T. (2019). Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms. Int. J. Mol. Sci.","DOI":"10.3390\/ijms20163940"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s11102-017-0791-0","article-title":"Somatostatin receptor ligands in the treatment of acromegaly","volume":"20","author":"Gadelha","year":"2017","journal-title":"Pituitary"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1210\/clinem\/dgab125","article-title":"Machine Learning-based Prediction Model for Treatment of Acromegaly With First-generation Somatostatin Receptor Ligands","volume":"106","author":"Wildemberg","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_12","first-page":"38","article-title":"Low somatostatin receptor subtype 2, but not dopamine receptor subtype 2 expression predicts the lack of biochemical response of somatotropinomas to treatment with somatostatin analogs","volume":"36","author":"Wildemberg","year":"2013","journal-title":"J. Endocrinol. Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1530\/ERC-18-0565","article-title":"Molecular profiling for acromegaly treatment: A validation study","volume":"27","author":"Gil","year":"2020","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1210\/clinem\/dgab726","article-title":"The Future of Somatostatin Receptor Ligands in Acromegaly","volume":"107","author":"Gadelha","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.critrevonc.2015.10.003","article-title":"Exploring miRNA based approaches in cancer diagnostics and therapeutics","volume":"98","author":"Mishra","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.7150\/ijbs.47203","article-title":"miRNA-based biomarkers, therapies, and resistance in Cancer","volume":"16","author":"He","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Denes, J., Kasuki, L., Trivellin, G., Colli, L.M., Takiya, C.M., Stiles, C.E., Barry, S., de Castro, M., Gadelha, M.R., and Korbonits, M. (2015). Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0117107"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1002\/ijc.33268","article-title":"miR-34a is upregulated in AIP-mutated somatotropinomas and promotes octreotide resistance","volume":"147","author":"Bogner","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/onc.2012.190","article-title":"Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway","volume":"32","author":"Palumbo","year":"2013","journal-title":"Oncogene"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1746-1596-5-79","article-title":"Differential expression of microRNAs in GH-secreting pituitary adenomas","volume":"5","author":"Mao","year":"2010","journal-title":"Diagn. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3171\/2014.12.JNS141083","article-title":"Invasion of the cavernous sinus space in pituitary adenomas: Endoscopic verification and its correlation with an MRI-based classification","volume":"122","author":"Micko","year":"2015","journal-title":"J. Neurosurg."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1111\/jcmm.13427","article-title":"Molecular evidence and clinical importance of \u03b2-arrestins expression in patients with acromegaly","volume":"22","author":"Coelho","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12022-008-9029-z","article-title":"Clinicopathological features of growth hormone-producing pituitary adenomas: Difference among various types defined by cytokeratin distribution pattern including a transitional form","volume":"19","author":"Obari","year":"2008","journal-title":"Endocr. Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"E66","DOI":"10.1210\/jc.2012-2609","article-title":"Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly","volume":"98","author":"Gatto","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13148-016-0287-1","article-title":"cPAS-based sequencing on the BGISEQ-500 to explore small non-coding RNAs","volume":"8","author":"Fehlmann","year":"2016","journal-title":"Clin. Epigenetics"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"D155","DOI":"10.1093\/nar\/gky1141","article-title":"miRBase: From microRNA sequences to function","volume":"47","author":"Kozomara","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"W530","DOI":"10.1093\/nar\/gkz415","article-title":"sRNAbench and sRNAtoolbox 2019: Intuitive fast small RNA profiling and differential expression","volume":"47","author":"Rueda","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1365-2265.2011.04163.x","article-title":"Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly","volume":"76","author":"Fougner","year":"2012","journal-title":"Clin. Endocrinol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11102-016-0768-4","article-title":"Somatostatin receptor ligands in acromegaly: Clinical response and factors predicting resistance","volume":"20","author":"Paragliola","year":"2017","journal-title":"Pituitary"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s40618-015-0306-7","article-title":"Expression of somatostatin receptor subtype 2 in growth hormone-secreting pituitary adenoma and the regulation of miR-185","volume":"38","author":"Fan","year":"2015","journal-title":"J. Endocrinol. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.mam.2019.10.007","article-title":"Altered expression of miR-181 affects cell fate and targets drug resistance-related mechanisms","volume":"70","author":"Braicu","year":"2019","journal-title":"Mol. Asp. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.freeradbiomed.2019.12.043","article-title":"microRNA-181 serves as a dual-role regulator in the development of human cancers","volume":"152","author":"Rezaei","year":"2020","journal-title":"Free. Radic. Biol. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JME-14-0034","article-title":"Somatostatin system: Molecular mechanisms regulating anterior pituitary hormones","volume":"53","author":"Eigler","year":"2014","journal-title":"J. Mol. Endocrinol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"59273","DOI":"10.18632\/oncotarget.11150","article-title":"Targeting the RAS\/MAPK pathway with miR-181a in acute myeloid leukemia","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s10020-021-00341-z","article-title":"A CREB1-miR-181a-5p loop regulates the pathophysiologic features of bone marrow stromal cells in fibrous dysplasia of bone","volume":"27","author":"Fu","year":"2021","journal-title":"Mol. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1002\/jcb.26000","article-title":"STAT1 Inhibits MiR-181a Expression to Suppress Colorectal Cancer Cell Proliferation Through PTEN\/Akt","volume":"118","author":"Zhang","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrc3037","article-title":"PTEN loss in the continuum of common cancers, rare syndromes and mouse models","volume":"11","author":"Hollander","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3892\/ijo.2017.4007","article-title":"miR-181b-5p mediates TGF-\u03b21-induced epithelial-to-mesenchymal transition in non-small cell lung cancer stem-like cells derived from lung adenocarcinoma A549 cells","volume":"51","author":"Li","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"313","DOI":"10.7150\/jca.64846","article-title":"A Concise Review of MicroRNA-383: Exploring the Insights of Its Function in Tumorigenesis","volume":"13","author":"Yi","year":"2022","journal-title":"J. Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10528-017-9794-9","article-title":"Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas were Identified by Using Analysis of microRNAs Expression Profile","volume":"55","author":"Wu","year":"2017","journal-title":"Biochem. Genet."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.biopha.2016.07.038","article-title":"Inhibition of microRNA-383 has tumor suppressive effect in human epithelial ovarian cancer through the action on caspase-2 gene","volume":"83","author":"Liu","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.tcb.2021.03.002","article-title":"Caspase-2 as a master regulator of genomic stability","volume":"31","author":"Kopeina","year":"2021","journal-title":"Trends Cell Biol."},{"key":"ref_48","first-page":"3181","article-title":"MicroRNA-383 upregulation protects against propofol-induced hippocampal neuron apoptosis and cognitive impairment","volume":"15","author":"Wang","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"188393","DOI":"10.1016\/j.bbcan.2020.188393","article-title":"PERP-ing into diverse mechanisms of cancer pathogenesis: Regulation and role of the p53\/p63 effector PERP","volume":"1874","author":"Roberts","year":"2020","journal-title":"Biochim. Et Biophys. Acta Rev. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1159\/000507890","article-title":"Pharmacological Acromegaly Treatment: Cost-Utility and Value of Information Analysis","volume":"111","author":"Leonart","year":"2021","journal-title":"Neuroendocrinology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1210\/jc.2007-1358","article-title":"Correlation of in vitro and in vivo somatotropic adenoma responsiveness to somatostatin analogs and dopamine agonists with immunohistochemical evaluation of somatostatin and dopamine receptors and electron microscopy","volume":"93","author":"Ferone","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2875\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:21:59Z","timestamp":1760120519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":51,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ijms24032875"],"URL":"https:\/\/doi.org\/10.3390\/ijms24032875","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,2]]}}}